Home › Stroke › NCT06516588

tDCS for Post-Stroke Cognitive Impairment

Post-Stroke Cognitive Impairment: Neurovascular Mechanisms and Non-Invasive Brain Stimulation

Who can join

Ages 18 to 99 · All sexes

Inclusion Criteria:

1\) ischemic stroke participants in sub-acute phase (at least 10 days after stroke event or discharge and under 5 months post-event) with cognitive dysfunction (MoCA \<26);

Exclusion Criteria:

1. clinically significant or unstable medical or psychiatric condition;
2. diagnosis of severe depression;
3. history of relevant neurological diagnosis (e.g., epilepsy);
4. previous neurosurgical procedure with craniectomy;
5. contraindications to tDCS (implanted brain medical devices);
6. severe visual impairment, hearing impairment, aphasia, neglect or dementia.

About the study

This study will evaluate the effects of a form of non-invasive brain stimulation on brain functioning and memory in participants with post-stroke cognitive impairment (PSCI).

What is being tested

• Transcranial Dirrect Current Stimulation (device)

Sponsor: University of Oklahoma · Participants: 80 · Started: Sep 30, 2024

Contact the study team

• Cheryl Adams, RN · Phone: (405) 271-8130
• Camila Bonin Pinto, PhD · Phone: (405) 271-8130

Official record on ClinicalTrials.gov — NCT06516588

Locations in the U.S.

Conditions

• Stroke
• Mild Cognitive Impairment

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.